GlassScriptPhysician profile
David H Warby
NPI 1912949421
$4,828.07
in general payments reported to CMS, 2019-2025
20 companies · $410 in 2025
The $410 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,284 · 2020: $45.66 · 2021: $1,046 · 2022: $1,705 · 2023: $274 · 2024: $63.44 · 2025: $410.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $748.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $747.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Anika Therapeutics, INC. | $1,832.80 | 2021-2025 | Integrity Implant |
| Zimmer Biomet Holdings, INC. | $1,213.66 | 2019 | |
| Treace Medical Concepts, INC. | $759.40 | 2021-2022 | |
| Sanara Medtech INC. | $165.56 | 2025 | Celleraterx |
| Stryker Corporation | $160.64 | 2023-2025 | Variax, Ortholoc 2 Lapifuse, Dart-Fire |
| Bone Support INC. | $144.89 | 2025 | Ceramentbone Void Filler, Cerament G |
| Integra Lifesciences Corporation | $99.71 | 2019-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Trice Medical, INC. | $95.16 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $87.06 | 2022-2023 | Seglentis |
| Dynasplint Systems INC. | $60.54 | 2021 | |
| Tenex Health INC. | $40.23 | 2021 | |
| Triad Life Sciences INC. | $38.07 | 2021 | |
| Solventum Corporation | $22.02 | 2025 | Prevena |
| Orthofix Medical, INC. | $19.89 | 2023 | Physio-Stim |
| Averitas Pharma INC. | $17.72 | 2024 | Qutenza |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wright Medical Technology, INC. | $17.13 | 2019 | |
| Polynovo North America LLC | $16.24 | 2023 | |
| Arthrosurface Incorporated | $12.71 | 2019 | |
| Organogenesis INC. | $12.53 | 2021 | |
| Allergan, INC. | $12.11 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Warby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.